Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment
Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment Phase 3…
Dassault Systmes : Half-year statement of the Liquidity contract entered into with Oddo BHF SCA
Press ReleaseVELIZY-VILLACOUBLAY, France — January 6, 2025 Half-year statement of the Liquidity…
Abivax Announces a Change to the Composition of its Board of Directors
Abivax Announces a Change to the Composition of its Board of Directors…
Quadient strengthens its financial position with a USD50million bank loan from Bank of America
Quadient strengthens its financial position with a USD50 million bank loan from Bank…
NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024
Participants can register here for the virtual event airing 9:00am ET /…
Nyxoah Announces Commercial Launch of Genio Innovative Therapy in England
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in EnglandFirst patients implanted…
Planisware enters the index SBF 120
Planisware enters the SBF 120 index Paris, France, 13 December, 2024 -…
Monthly information on share capital and company voting rights
PARIS, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN…
Exosens enters into exclusive negotiations to acquire Noxant, specialized in high performance cooled infrared cameras
EXOSENS ENTERS INTO EXCLUSIVE NEGOTIATIONS TO ACQUIRE NOXANT, SPECIALIZED IN HIGH PERFORMANCE…
Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting
NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext…